These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 29719870)

  • 41. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VacSol-ML(ESKAPE)
    Nasir S; Anwer F; Ishaq Z; Saeed MT; Ali A
    Vaccine; 2024 Sep; 42(22):126204. PubMed ID: 39126830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria.
    Reza A; Sutton JM; Rahman KM
    Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31752382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens.
    Tse MW; Zhu M; Peters B; Hamami E; Chen J; Davis KP; Nitz S; Weller J; Warrier T; Hunt DK; Morales Y; Kawate T; Gaulin JL; Come JH; Hernandez-Bird J; Huo W; Neisewander I; Kiessling LL; Hung DT; Mecsas J; Aldridge BB; Isberg RR; Blainey PC
    bioRxiv; 2024 Mar; ():. PubMed ID: 38585790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms.
    Lee NY; Ko WC; Hsueh PR
    Front Pharmacol; 2019; 10():1153. PubMed ID: 31636564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms.
    Hoenes K; Bauer R; Meurle T; Spellerberg B; Hessling M
    Front Microbiol; 2020; 11():612367. PubMed ID: 33519770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients.
    Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A
    Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Draft Genome Sequences of Acinetobacter baumannii Isolates from Wounded Military Personnel.
    Arivett BA; Ream DC; Fiester SE; Kidane D; Actis LA
    Genome Announc; 2016 Aug; 4(4):. PubMed ID: 27563036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
    Sandiumenge A; Rello J
    Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial, Antibiofilm, and Antioxidant Properties of
    Garcia J; Rodrigues F; Castro F; Aires A; Marques G; Saavedra MJ
    Front Nutr; 2021; 8():773346. PubMed ID: 35281762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
    Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
    Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ESKAPE Pathogens: Antimicrobial Resistance Patterns, Risk Factors, and Outcomes a Retrospective Cross-Sectional Study of Hospitalized Patients in Palestine.
    Abukhalil AD; Barakat SA; Mansour A; Al-Shami N; Naseef H
    Infect Drug Resist; 2024; 17():3813-3823. PubMed ID: 39247758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary.
    Orosz L; Lengyel G; Ánosi N; Lakatos L; Burián K
    Acta Microbiol Immunol Hung; 2022 Jan; ():. PubMed ID: 35084364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.
    Vale de Macedo GHR; Costa GDE; Oliveira ER; Damasceno GV; Mendonça JSP; Silva LDS; Chagas VL; Bazán JMN; Aliança ASDS; Miranda RCM; Zagmignan A; Monteiro AS; Nascimento da Silva LC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33540588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.
    Jadimurthy R; Mayegowda SB; Nayak SC; Mohan CD; Rangappa KS
    Biotechnol Rep (Amst); 2022 Jun; 34():e00728. PubMed ID: 35686013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.